Mahima

APLICATIONS

New Drug Approval

New Drug Approval | USFDA Approves Vyvgart Hytrulo for Subcutaneous Use...

Harish Chawla - June 22, 2023 0

VYVGART® Hytrulo is the first FDA-approved subcutaneous (SC) injectable for generalized myasthenia gravis (gMG) SAN DIEGO, June 20, 2023 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme")...

Leaves – Types and Details

April 16, 2020

Are You Aspiring Area Manager? Click to Understand what you Need...

July 10, 2020

Most Important Questions for Interview Preparation

April 7, 2020

HOT NEWS

Learning and Development

What is the Induction of a Medical Representative? | Free Webinar...

Interview Questions

Most Important Questions for Interview Preparation

New Drug Approval

New Drug Approval | Sarepta Therapeutics Announces FDA Approval of ELEVIDYS,...

Role and Responsibilities